[Key specialties edition] Outpatient vs. inpatient orthopedic procedures: Where are the cost-savings? | Valeant Pharmaceuticals' Salix to pay $54M for alleged illegal kickbacks: 6 things to know | Pain management device market to hit $4.64B by 2021: 5 things to know | Zimmer Biomet to acquire LDR in $1B transaction

Text

In this newsletter, you will find content related to key specialties including spine, orthopedics, ophthalmology, gastroenterology and pain management.

June 21, 2016

Today's Top Articles

1. Valeant Pharmaceuticals' Salix to pay $54M for alleged illegal kickbacks: 6 things to know Full story

2. Outpatient vs. inpatient orthopedic procedures: Where are the cost-savings? Full story

3. Zimmer Biomet to acquire LDR in $1B transaction - 9 things to know Full story

4. Whitepaper: Healthcare consumerism is here - a patient acquisition model that you fully control and own. Click here to learn more and download.

5. 8 statistics on payers, new payment models & ophthalmologists Full story

6. From pre-op to post-op: A team-based approach to adding TJR to an ASC Full story

7. Webinar: Learn how to navigate the reimbursement landscape for total joint reconstruction in ASCs. Register today!

8. Outpatient spine driving spinal implants market growth; CAGR of 5.91% to 2020 - 5 observations Full story

9. Top 10 states with highest follow-up interval for colonoscopy rates Full story

10. Pain management device market to hit $4.64B by 2021: 5 things to know Full story

11. Evolutionary vs. revolutionary: The future of surgical devices and spine surgery Full story